Physician profile
Judith C Brooks
NPI 1235398025
$1,713.86
in general payments reported to CMS, 2019-2025
13 companies · $803 in 2025
The $803 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2022: $128 · 2023: $263 · 2024: $331 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,396.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $488.04 | 2019-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $341.57 | 2024-2025 | Breztri, Airsupra |
| Glaxosmithkline, LLC. | $265.53 | 2022-2023 | Trelegy Ellipta |
| Amgen INC. | $132.13 | 2024-2025 | Otezla, Repatha, Repatha |
| Otsuka America Pharmaceutical, INC. | $119.87 | 2025 | Rexulti |
| Astellas Pharma US INC | $110.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $65.48 | 2019 | |
| Corcept Therapeutics | $53.16 | 2025 | Korlym |
| Lilly USA, LLC | $39.67 | 2024-2025 | Zepbound, Mounjaro |
| Neurocrine Biosciences, INC. | $30.31 | 2025 | |
| Exact Sciences Corporation | $27.76 | 2024 | Cologuard Collection Kit |
| Abbott Laboratories | $22.90 | 2024 | Aveir |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.44 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.